Facts
-
Science & Education -
-
The consortium will use this funding to develop AI methods
The European consortium ARTILLERY (Artificial Intelligence for early detection of non-communicable disease risk in people with breast cancer) has been awarded a Horizon Europe grant of 6 million euros. With this funding, the consortium will develop AI methods that can help predict the risk of developing chronic diseases in (former) breast cancer patients. Lenny Verkooijen of UMC Utrecht is the consortium’s main applicant/lead applicant.
Thanks to ever better care and treatments, patients with breast cancer are living longer. However, the treatments, such as chemotherapy or radiotherapy, entail an increased risk of chronic diseases for these (former) patients, such as obesity or cardiovascular disease. These diseases have a negative impact on the quality of life after breast cancer.
Info from scans
Many breast cancer patients are treated with radiotherapy (irradiation). CT scans are made in these patients to plan the radiation treatments. In addition to information about where the tumor is located, these scans also contain information about predictive factors for the development of chronic diseases after the treatment process. For example, the presence of calcium in the coronary arteries of the heart, which is visible on the scans, appears to be a good predictor for the occurrence of cardiovascular disease. And an unfavorable distribution of fat and muscle tissue is predictive of chemotherapy side effects.
Benefits for the patient at the center
This information may be valuable but is currently not reported and used by physicians in their daily practice. The ARTILLERY consortium will develop AI methods to quickly and reliably identify the risk factors hidden in regular CT scans. Both patients and practitioners are part of the consortium to ensure that only algorithms are developed that are relevant to both patient and doctor. Together with methodologists, medical ethicists and lawyers, we are investigating whether the theoretical advantages of the algorithms actually benefit patients. The researchers will also carefully map out potential adverse effects (false alarms, stigmatisation, privacy).
Additional information …
Consult the source and/or provider for more information about this message. News may change, include errors or inaccuracies. Also read our disclaimer and please report messages, comments and/or images that go against our terms and conditions.
Click on the tags below for relevant posts, if any…
- Author name and/or edited by:
UMC Utrecht - Photographer or photo agency: :
INGImages - Source for this article: :
UMC Utrecht - What is the URL at this source?:
https://www.umcutrecht.nl/nieuws/6-miljoen-voor-europees-artillery-consortium - Original title:
6 million for European ARTILLERY consortium - Target audience:
Healthcare Professionals, Students - Datum:
2022-12-15
Articles with similar tags …